Top Markets
Coin of the day
Petros Pharmaceuticals, Inc. Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals, Inc.

PTPI
Classement en actions #40525
Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male... Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male health solutions. Their activities include both the commercialization and ongoing development of Stendra, a prescription PDE-5 inhibitor specifically designed for treating erectile dysfunction (ED). Furthermore, Petros is advancing H100, a proprietary topical formulation currently in development as a potential treatment for acute Peyronie's disease. The company's offerings also extend to a range of erectile dysfunction products, such as vacuum erection devices. Petros Pharmaceuticals, Inc. operates from its base in New York, New York.
Prix de l'action
$0.0034
Capitalisation boursière
$144.07K
Changement (1 jour)
13.33%
Changement (1 an)
-88.67%
Pays
US
Échange Petros Pharmaceuticals, Inc. (PTPI)

Catégorie

Historique du rendement du dividende pour Petros Pharmaceuticals, Inc. (PTPI)
Le rendement du dividende (TTM) de Petros Pharmaceuticals, Inc. (symbole boursier : PTPI) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de Petros Pharmaceuticals, Inc. (PTPI) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
Pas assez de données pour les dates fournies.
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes